Dr Raghav said: “In June 2019, the patient had increasing symptoms of shortness of breath and fatigue, and scans showed disease progression in both the lungs and the liver.
“Patient was then switched to 5-fluorouracil, leucovorin, irinotecan and cetuximab and received this treatment until August 2020 with stable disease as the best response.
“In August 2020, the patient had progressive disease and was given regorafenib.”
He added: “Interestingly, it’s strange that the patient developed this disease in a rather short interval from the last colonoscopy, which was completely negative.”
Related Posts
Denial of responsibility! TechnoCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
